Effect of desipramine on norepinephrine metabolism in humans: interaction with aging.
To determine whether differences in neuronal reuptake contribute to age-related changes of sympathetic nervous system activity, we compared norepinephrine (NE) release and metabolism during [3H]NE infusion and decay in six young (age 19-26 yr) and seven older (age 61-73 yr) healthy nonobese subjects. Subjects were studied on a control day and on a separate day after desipramine (DMI; 125 mg orally), a neuronal reuptake blocker. Compartmental analysis of plasma NE specific activity was used to determine several NE kinetic parameters. Plasma NE levels and NE spillover rates were higher in the elderly. Although plasma NE was unaffected by DMI in both age groups, both the metabolic clearance rate of NE from plasma and the rate of NE spillover into plasma fell in young and older groups during DMI. Furthermore, DMI dramatically lowered the mass of NE in the extravascular compartment and the rate of NE entry into the extravascular compartment. Thus neuronal uptake blockade has major effects on NE release as well as NE metabolism in humans. However, age-related differences in NE kinetics cannot be explained by differences in neuronal uptake.
Stromberg
J S
JS
Department of Internal Medicine, University of Michigan, Ann Arbor.
Linares
O A
OA
Supiano
M A
MA
Smith
M J
MJ
Foster
A H
AH
Halter
J B
JB
D000328:Adult; D000368:Aged; D000375:Aging / Q000378:metabolism*; D003891:Desipramine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D013564:Sympathetic Nervous System / Q000502:physiology
D003891:Desipramine; D009638:Norepinephrine